Back to GLENMEDE TRUST CO NA

ABT
Showing 6 of 29 quarters

Position history for GLENMEDE TRUST CO NA's holdings in ABBOTT LABORATORIES

GLENMEDE TRUST CO NA holds 1.1M shares of ABT (ABBOTT LABORATORIES), worth $109.8M as of 2026-Q1. The position was decreased (-5.7% shares). ABT represents 0.5% of GLENMEDE TRUST CO NA's portfolio.

Current Value

$109.8M

Current Shares

1.1M

Total Value Change

-$49.8M

Total Shares Change

-466,292

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.1M
-5.7%
$109.8M0.5%$113.61
0
2025-Q4
Decreased
1.1M
-13.3%
$142.2M0.7%$125.15
0
2025-Q1
Decreased
1.3M
-4.1%
$173.7M0.9%$128.41
0
2024-Q4
Decreased
1.4M
-10.0%
$154.4M0.8%$110.14
0
2024-Q3
Decreased
1.5M
-1.3%
$172.9M0.8%$109.27
0
2024-Q2
Increased
1.5M
+0.8%
$159.6M0.8%$100.45
43

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used